Answers are grounded in this paper and cite their sources.
This study describes the radioiodination of an antibody specific to the vascular endothelial growth factor (VEGF), VG76e, with [124I]iodine to obtain a novel PET tracer for measurement of angiogenesis. In vitro binding assays showed a significantly higher immunoreactive fraction with the protein labelling reagent N‐succinimidyl 3‐(4‐hydroxy‐5‐[125I]iodophenyl) propionate ([125I]Bolton–Hunter reagent, [125I]I‐SHPP) (34.0±4.0%) as compared with N‐succinimidyl 3‐[125I]iodobenzoate (10.9±6.4%) or direct radioiodination using [125I]iodide and IodoGen (3.1±3.0%). Consequently, the cyclotron–produced positron–emitting [124I]iodine (T1/2=4.2 days) was employed to prepare [124I]I‐SHPP. Using an improved radioiodination methodology, [124I]I‐SHPP was prepared from sodium [124I]iodide with IodoGen at pH 6.5. The [124I]Bolton–Hunter reagent was isolated with 25–58% (n=3) radiochemical yield and 88–95% (n=3) radiochemical purity by the conventional extraction procedure. The conjugate of VG76e with [124I]I‐SHPP was prepared with 17–18% (n=3) labelling efficiency and 98% radiochemical purity. The immunoreactive fraction was determined to be 33.5% (n=2).
No takes yet. Share an insight, caveat, or question.
Glaser et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: